BDBM260210 US9522914, A-12

SMILES COc1cc(ccc1F)-c1nc(cn1CC(=O)NC(C)C)-c1ccc(CCN2CCC[C@H]2C)cc1

InChI Key InChIKey=ZYMUCGGXBMXVCH-HXUWFJFHSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 260210   

TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260210(US9522914, A-12)
Affinity DataIC50:  17nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260210(US9522914, A-12)
Affinity DataIC50:  17nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent